SciELO - Scientific Electronic Library Online

 
vol.46 número3Biosurfactant production by Pseudomonas aeruginosain kefir and fish mealInterspecific transmission of small ruminant lentiviruses from goats to sheep índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

Compartilhar


Brazilian Journal of Microbiology

versão impressa ISSN 1517-8382versão On-line ISSN 1678-4405

Braz. J. Microbiol. vol.46 no.3 São Paulo jul./set. 2015  Epub 21-Jul-2015

http://dx.doi.org/10.1590/S1517-838246320140051 

Veterinary Microbiology

Assessment of the pathogenicity of cell-culture-adapted Newcastle disease virus strain Komarov

Sivam Visnuvinayagam1 

Thangavel K2 

Lalitha N3 

Malmarugan S4 

Kuppannan Sukumar2 

1Mumbai Research Centre, Central Institute of Fisheries Technology, Mumbai, India.

2Veterinary College and Research Institute, Tamil Nadu, India.

3Central Institute of Brackishwater Aquaculture, Tamil Nadu, India.

4Veterinary College, Tamil Nadu, India.

ABSTRACT

Newcastle disease vaccines hitherto in vogue are produced from embryonated chicken eggs. Egg-adapted mesogenic vaccines possess several drawbacks such as paralysis and mortality in 2-week-old chicks and reduced egg production in the egg-laying flock. Owing to these possible drawbacks, we attempted to reduce the vaccine virulence for safe vaccination by adapting the virus in a chicken embryo fibroblast cell culture (CEFCC) system. Eighteen passages were carried out by CEFCC, and the pathogenicity was assessed on the basis of the mean death time, intracerebral pathogenicity index, and intravenous pathogenicity index, at equal passage intervals. Although the reduction in virulence demonstrated with increasing passage levels in CEFCC was encouraging, 20% of the 2-week-old birds showed paralytic symptoms with the virus vaccine from the 18th(final) passage. Thus, a tissue-culture-adapted vaccine would demand a few more passages by CEFCC in order to achieve a complete reduction in virulence for use as a safe and effective vaccine, especially among younger chicks. Moreover, it can be safely administered even to unprimed 8-week-old birds.

Key words: Newcastle disease; Komarov strain; chicken embryo fibroblast; Newcastle disease vaccine

Introduction

Newcastle disease (ND) is a highly contagious viral disease of poultry that is caused by avian paramyxovirus serotype 1 (APMV 1), which together with viruses of other APMV serotypes (APMV 2-9) has been placed in the genus Avulavirus, subfamily Paramyxovirinae, and family Paramyxoviridae (Deleeuw and Peeters, 1999; Orsi et al., 2010a).

The mesogenic Mukteswar strain was independently developed in India by G.S. Iyer through egg passage. Subsequently, the mesogenic Komarov strain was obtained by A. Komarov in Palestine, via serial passages of the virulent strain through ducklings (Czegledi et al., 2003). The Komarov vaccine, also known as the Haifa vaccine strain (Mazia, 1990), is being used by most of the African countries and is less pathogenic than the Mukteswar strain (Grimes, 2002).

For several years now, embryonated chicken egg (ECE) adapted mesogenic live vaccines (strains K, R2B, etc.) have been employed only among 8-week-old chicks that had already been primed at 2 weeks of age with a lentogenic vaccine such as strains LaSota, F, etc. (Reddy and Srinivasan, 1992; OIE, 2008). Otherwise, the mesogenic vaccine causes mortality in unprimed chicks, even at the age of 8 weeks. Mesogenic vaccines may predispose the poultry flock to viral and secondary bacterial infections (Bhaiyat et al., 1994; Orajaka and Ezema, 2004; Saif et al., 2008)

Owing to the drawback of mesogenic strains, the Commission of the European Communities (CEC) recommended against the use of vaccines containing an intracerebral pathogenicity index (ICPI) value of more than 0.4 (CEC, 1993). Since, all mesogenic vaccines have an ICPI value of more than 0.4, only lentogenic strain vaccines are permitted to be used. Available lentogenic strains are very mild in nature; thus, a lentogenic strain that produces not adequate immunity. Hence, it is required to reduce the virulence of the mesogenic strain to a lentogenic in such a way as to maintain an ICPI value close to 0.4 for producing a better immunity in birds. Keeping in view the above-mentioned drawbacks from the virulent nature of mesogenic strains and the CEC standards, an attempt was made to reduce the mesogenic virulence to a lentogenic virulence level by chicken embryo fibroblast cell culture (CEFCC). Pathogenicity trials of the tissue culture (TC)-passaged NDV strain K vaccine virus were conducted in vitro and in vivo, at various passage levels, to assess the extent of reduction in virulence, with the aim for it to be used in all age group of chicks, possibly without any post-vaccinal reactions.

Materials and Methods

NDV strain K vaccine

The freeze-dried RDV strain K vaccine virus was procured from the Institute of Veterinary Preventive Medicine, Raniphet, Tamil Nadu, India.

Embryonated chicken eggs

Embryonated chicken eggs were obtained from specific pathogen-free birds, which were maintained in the Department of Veterinary Microbiology, Veterinary College and Research Institute, Namakkal, India.

Birds

Day-old Babcock male chicks were procured from commercial hatcheries at Namakkal, India.

Preparation of “seed” virus for the first passage in chicken embryo fibroblast primary cell culture

One mL of freeze-dried vaccine virus was reconstituted and diluted to 1:1000 with phosphate-buffered saline, and then antibiotics were added at 200 IU of benzyl penicillin, 200 μg of streptomycin sulfate, and 200 IU of nystatin per milliliter of inoculum, to prevent bacterial and fungal contaminations. After the “processed” seed virus had been incubated at 37 °C for 30 min, it was inoculated into five 9-day-old ECEs. The eggs were then placed in an incubator containing a water tray in order to maintain the humidity at 60–65% with a set temperature of 38° C. Amnio-allantoic fluid (AAF) was harvested from the infected embryos, which had died after 24 h. The harvested AAF was centrifuged for 30 min at 3000 rpm at 4 °C and the supernatant was frozen at −20 °C as 2 mL aliquots. These aliquots were employed as seed virus for the first passage in CEFCC. The embryos were observed for embryopathy and specific lesions caused by the virus (Grimes, 2002).

Chicken embryo fibroblast primary cell culture

Ten-day-old actively moving embryos were used for the cell culture, and the rapid trypsinization procedure was carried out by employing 0.25% trypsin. The trypan blue dye exclusion technique was used for determining the viable cell count with the aid of a hemocytometer, and the cell concentration was adjusted to 2 × 106 cells/mL with growth medium. The cells were seeded in culture bottles, incubated at 37 °C, and then observed for confluent monolayers (Freshney, 2010).

Passaging of virus in CEFCC

Culture flasks with an 80% monolayer were inoculated with 1 mL of undiluted embryo-propagated virus (i.e., AAF). After a 60–90 min adsorption time at 37 °C, the monolayer was washed with maintenance medium and then covered with the same medium. The occurrence of any cytopathic effect (CPE) was observed at 8 h intervals (Freshney, 2010).

Infection of subsequent passages

The “start-up” virus of each passage was subjected to three freeze-thaw cycles, followed by a light clarifying centrifugation to remove cell debris, and the supernatant was used for further passages. In the case of the serial blind passages, the undiluted inoculum was used as the seed virus. For active passages, a 1:100 dilution of previous passages was used as the seed material. Production of about 80% CPE was taken to be the harvesting criterion. The culture fluids with maximum CPE were preserved at −20 °C and used as the inoculum for the second passage. Similarly, the cell culture fluid of the previous passage was used for subsequent passages, up to the 18th passage level (Schat and Purchase, 1989).

Passages in CEFCC

In total, 18 passages could be carried out with the CEFCC system. Although visible CPEs could already be noticed after four blind passages, the infected TC fluids of all blind passages were nonetheless confirmed for the presence of virus by inoculation in ECEs. Similar recordings were made in the case of 14 “active” passages, along with observation of specific CPE. A microtitration technique with a 10-fold dilution was used to assess the TCID50 value for alternative passages (Schat and Purchase, 1989). Micro-hemagglutination (HA) tests were also conducted with the seed and all the cell-culture-passaged viruses (OIE, 2008).

Modified spot or rapid HA test

The spot HA test is a rapid test used to identify the presence of a virus in the egg/TC bottle. One milliliter of the AAF or 1 mL of TC fluid was added to 1 mL of 33.3% chicken red blood cells (CRBC) held in a white porcelain plate. Both the CRBC and test samples were properly mixed and observed for HA within 1 min (Grimes, 2002; Ullah et al., 2004).

Pathogenicity indices

The extent of reduction in virulence of the NDVK (mesogenic) strain was assessed on the basis of pathogenicity indices; namely, mean death time (MDT) in 9-day-old embryos, intracerebral pathogenicity index (ICPI) in day-old chicks, and intravenous pathogenicity index (IVPI) in 6-week-old chicks, conducted using seed virus and TC-passaged viruses (5th, 10th, 15th, and 18th passages). A reduction in the virulence of the TC-adapted virus was further confirmed by inoculating it into 2-week-old and 8-week-old chicks (OIE, 2008).

Results

The revived freeze-dried egg-adapted vaccine virus, which served as seed material for passage in the TC system, possessed high HA (210) and EID50(107.5) titers. The potency of the seed virus was further confirmed by the appearance of specific lesions in the ECEs; namely, occipital and pedal hemorrhages (Figure 1). No significant (cytopathic) changes were noticed in the CEFCC system for up to three passages. However, the virus presence was confirmed by the observation of specific lesions in the ECEs. Adaptation of the virus in CEFCC was observed (CPE initiation) from the 4th passage onwards, and the extent of the CPE increased with progressive passages upto the 18th/final passage of this study (Figures 2A and 2B)

Figure 1 Specific lesions: Occipital and pedal hemorrhages. (A) Seed-virus-infected embryo showing typical occipital hemorrhage. (B) Passaged (5th) virus-inoculated embryo showing mild occipital hemorrhage. (C) Uninoculated control without any occipital hemorrhage 

Figure 2 (A) Uninfected chicken embryo fibroblast (CEF) monolayer. (B) Infected chicken embryo fibroblast monolayer showing clumping, rounding, and syncitial formations of the CEF cells 

The TCID50 titers of active passages increased from 103.4/mL (4th passage) to 105.3/mL (18th passage). Similarly, the EID50 titers of the TC-passaged viruses also increased from 103.4/mL (2nd passage) to 106.2/mL (18th passage) (Figure 3).

Figure 3 EID50 and TCID50 titers of the seed and TC-passaged viruses 

The MDT increased from 71.4 h (5th passage) to 92.1 h (18th/final passage). The ICPI value decreased by 0.1 in the case of the 5th passage (1.2) compared with the seed virus (1.3), and the value decreased further by 0.4 in the case of the 18th passage (0.8) relative to the 5th passage (1.2). The IVPI values of the seed and the selected TC-passaged viruses (5th, 10th, 15th, and 18th passages) were all zero (Table 1).

Table 1 Pathogenicity indices and number of birds showing symptoms with Newcastle disease virus strain K (NDVK) seed and tissue-culture-passaged viruses 

Seed (NDVK) 5th Passage 10th Passage 15th Passage 18th Passage
Pathogenicity indices MDT (h) 64 71.4 78.6 86.5 92.1
ICPI 1.3 1.2 1.1 0.9 0.8
IVPI 0.0 0.0 0.0 0.0 0.0
Percentage of infected birds Two weeks 80% 70% 50% 40% 20%
Eight weeks 10% 10% 0% 0% 0%

MDT: mean death time; ICPI: intra-cerebral pathogenicity index; IVPI, intravenous pathogenicity index.

Discussion

The NDVK seed virus demanded a few blind passages for adaptation in CEFCC. Similarly, Parimal and Padmanaban (1990) reported that the NDV Komarov strain adapted in CEFCC after four blind passages. However, Padmaraj et al. (1991) recorded two blind passages for NDVK in the BHK21 (Razi) cell line. After adaptation of the NDVK virus in CEFCC, lesions appeared after 48 h, and more pronounced CPEs were observed from the 7th passage onwards; later, the duration for CPE occurrence was reported to decrease from 48 h post-inoculation (p.i.; 5th passage) to 24 h p.i. (8th passage) (Padmaraj et al., 1991). Similarly, Joshi et al. (2002) observed cell rounding and clumping as early as 48 h p.i., and cellular degeneration within 96 h p.i.

The MDT values were increased and the ICPI values were decreased with our TC-passaged virus, which clearly indicates the difficulty of the egg-adapted virus in tissue culture. The reason could be attributed to the virus unable to replicate in the cell culture, owing to the absence of specific receptors, which leads to faulty production of the viral protein (Arora et al., 2003). The progress of the infectivity (TCID50 and EID50) was also in good accordance with the observations of Bansal and Kumar (1975).

OIE (2008) has established an ND virus to be a lentogenic strain if it has an MDT of more than 90 h and an ICPI value of less than 0.5. Thus, based on these criteria, the final passage of the virus (i.e., 18th passage) in our study fulfills only the MDT criterion, since it was more than 90 h (i.e., 92 h), but the ICPI value was more than 0.5 (i.e., 0.8). Oris et al.(2010b) characterized the isolated virus on the basis of the ICPI value alone and found it to be more important than the MDT value in establishing it as apathogenic strain. Hence, to meet the criteria of the Office International des Epizooties (OIE, 2008), the ICPI value of the virus needs to be reduced to 0.4. Thus, a few more passages are warranted to reduce the virulence to the lentogenic level.

The increase in MDT and decrease in ICPI values of the TC-passaged virus relative to the seed virus confirms the reduction in virulence of the seed or egg-adapted virus, when passaged in CEFCC. However, the reason for the IVPI value remaining as zero from the seed virus upto the final passage remains same is unexplainable; because, the “start-up” virus itself has a value of zero. Nevertheless, it at least indirectly indicates no increase in virulence.

In unprimed 8-week-old birds, 10% of the birds exhibited respiratory symptoms with the seed, and 5th and 10th passage viruses. However, the 15thand 18th passage viruses did not produce any specific symptoms. These results confirm that the Komarov vaccine causes respiratory symptoms in unprimed chicks, which correlates with the results of previous studies (Reddy and Srinivasan, 1992; OIE, 2008)

In 2-week-old chicks, the 5th passage virus elicited ND symptoms similar to the seed virus. The 18th passage virus elicited ND symptoms among 20% of the birds of this age, with lower intensity. The substantive reduction in number of chicks evincing ND symptoms with the 18th passage virus, with significant reduction in the intensity of the symptoms, clearly indicates a marked reduction in the virulence of the virus, when compared with the seed virus.

Elamin et al. (1993) experimentally verified that the nasal route of vaccination also gives similar immunity as wing-web method. This would facilitate our research, because the passaged Komarov strain could be safely and easily administered through the nasal route as with the lentogenic vaccine.

Conclusions

In conclusion, when NDVK chick-embryo-adapted vaccine viruses were passaged 18 times in the CEFCC system, the TCID50 values of the passaged viruses in TC and embryonating eggs are increased, indicating an increase in total infective particles and thus confirming the progressive adaptation of the virus in the CEFCC system. The values of the pathogenicity indices for the passaged viruses were altered towards those of lentogenic strains. However, the “actual” lentogenic values could not be reached. Hence, a few more passages are warranted to render the strain more lentogenic in nature for the safe use in 2-week-old chicks in order to give a better protective titer compared with other commercially available lentogenic vaccines.

Acknowledgement

The facility provided by TANUVAS for conducting this research is thankfully acknowledged.

References

Arora P, Garg SK, Lakhchaura BD et al. (2003) Adaptation of Newcastle disease virus in MDBK cell line. Ind Vet J 80:1072–1073. [ Links ]

Bansal MP, Kumar S (1975) Effect of propagation in pig kidney cell-culture on virulence of some strain of Ranikhet (Newcastle) disease virus. Ind J Anim Sci 45:470–473. [ Links ]

Bhaiyat MI, Ochiai K, Itakura C et al. (1994) Brain lesions in young broiler chickens naturally infected with a mesogenic strain of Newcastle disease virus. Avian Pathol 23:693–708. [ Links ]

CEC (1993) Commission of the European Communities. Commission Decision of 8 February 1993 laying down the criteria for vaccines to be used against Newcastle disease in the context of routine vaccination programmes. Off J European Communities, L59, 35. http://www.cfsph.iastate.edu/HPAI/resources/Additional%20Resources/OIEManual2_1_15.pdf. [ Links ]

Czegliidi A, Wehmann E, Lomniczi B (2003) On the origins and relationships of Newcastle disease virus vaccine strains Hertfordshire and Mukteswar, and virulent strain Herts’33. Avian Pathol 32:271–276. [ Links ]

Deleeuw O, Peeters B (1999) Complete nucleotide sequencing of Newcastle disease virus: evidence for the new genus within the subfamily Paramyxovirinae. J Gen Virol 80:131–136. [ Links ]

Freshney IR (2010) Culture of animal cells a manual of basic technique and specialized applications, 6th ed. Wiley-Blackwell publication. [ Links ]

Grimes SE (2002) A basic laboratory manual for the small scale production and testing of I - 2 Newcastle disease vaccine. RAP publication. FAO, Rome. [ Links ]

Joshi N, Garg SK, Chandra R et al. (2002) Adaptation of R2B strain of Newcastle disease virus in Vero cell line. Ind J Anim Sci 72:203–205. [ Links ]

Mazija H (1990) Newcastle disease - A special review of immunosupression. Options Méditerranéennes, 7. http://om.ciheam.org/om/pdf/a07/CI901591.pdf. [ Links ]

OIE (2008) Office International des Epizooties. Manual of diagnostic test and vaccines for terrestrial. 6th ed. Volume 1 Paris. http://www.oie.int/doc/ged/D7710.pdf. [ Links ]

Orajaka LJE, Ezema WS (2004) The effects of Newcastle disease vaccine (Komarov) on unvaccinated local hens. Nigerian Vet J 25:60–65. [ Links ]

Orsi MA, Doretto Jr. L, Camillo SCA et al. (2010a) Prevalence of newcastle disease virus in broiler chickens (Gallus gallus) in Brazil. Braz J Microbiol 41:349–357. [ Links ]

Orsi MA, Doretto Jr. L, Camillo SCA et al. (2010b) A survey for maintenance of virulent Newcastle disease virus-free area in poultry production in Brazil. Braz J Microbiol. 41:368–375. [ Links ]

Padmaraj A, Kumanan K, Vijayarani K et al. (1991) Adaptation of Newcastle disease virus BHK21 (Razi) cell line. Ind J Anim Sci 61:1059–1061. [ Links ]

Parimal R, Padmanaban VD (1990) Adaptation of Ranikhet disease virus (K strain) in chicken embryo fibroblast culture. Ind J Comp Microbiol Immunol Infect Dis 11:40–43. [ Links ]

Reddy GS, Srinivasan VA (1992) use of BHK cell culture adapted Newcastle disease virus for immunization of chicks, Vaccine 10:164–166. [ Links ]

Saif YM, Fadly AM, Glisson JR et al. (2008) Newcastle disease, other avian paramyxoviruses, and pneumovirus infections. In: Diseases of Poultry. Blackwell Publishing Professional, Ames, pp. 75–93. [ Links ]

Schat KA, Purchase HG (1989) A laboratory manual for the isolation and identification of avian pathogens. Purchase HG, Arp LH, Domermuth CH et al. (eds). The American Association of Avian Pathologist, Kendall / Hunt Publishing Company, Iowa, pp. 167–175. [ Links ]

Ullah S, Ashfaque M, Rahman SU et al. (2004) Newcastle disease virus in the intestinal contents of broilers and layers. Pak Vet J 24:28–30. [ Links ]

Received: January 21, 2014; Accepted: November 28, 2014

Send correspondence to S. Visnuvinayagam. Mumbai Research Centre, Central Institute of Fisheries Technology, Mumbai, India. E-mail: visnuvinayagam@yahoo.co.in.

Associate Editor: João Pessoa Araújo Junior

Creative Commons License All the content of the journal, except where otherwise noted, is licensed under a Creative Commons License CC BY-NC.